The Bosutinib Isomer- A Case for NMR ASV?
I've already described the Bosutinib fiasco in my last entry, and finished with a teaser that we would be back for more commentary on this topic. We plan a series of tests of our algorithms and systems to see if our software could have been used to prevent a situation like this. The main question...